Horizon Technology Finance (HRZN) is a Business Development Company (1099 Tax Form, No K-1) that has a well-diversified venture debt business in the life sciences, healthcare technology, sustainability, and tech sectors. They are currently undervalued because of investor hesitation in both the credit and venture capital markets, which HRZN happens to be at the intersection of.
The long term average yield of their debt portfolio is in the high teens, and in the most recent quarter was slightly decreased at 13.2%.
Generally, a life science/tech company would take a loan from HRZN as